All Stories

  1. The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients

    Article • Cancer Management and Research, September 2014, Taylor & Francis

    Mr Mikkel Staberg

  2. Identification of a novel antagonist of the ErbB1 receptor capable of inhibiting migration of human glioblastoma cells

    Article • Cellular Oncology, April 2013, Springer Science + Business Media

    Mr Mikkel Staberg